Drugs / IBI-20089
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01175395 | Sep 2010 → Jan 2013 | age-related macular degeneration, choroidal neovascularization | University of Illinois at Chicago | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IBI-20089 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01175395 ↗ |
| Known as | IBI-20089 (Triamcinolone Acetonide) | “IBI-20089 (Triamcinolone Acetonide)” NCT01175395 ↗ |
| Route | Intravitreal | “a single intravitreal injection of IBI-20089” PMID 25376617 ↗ Nov 2014 |